To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene PMS2L12andPRKRIP1andORAI2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
645 representative clones for gene PMS2L12andPRKRIP1andORAI2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA770788 brain .a 1 to 579 2 to 581   tiling clone, capped   580/580
(100 %)
1 diff
(99.9 %id)
BM423485 amelanotic melanoma, cell line, skin .a 13 to 805 1 to 802       802/1015
(79 %)
30 diff
(97.1 %id)
DA481951   .a 14 to 487 2 to 475   capped   474/474
(100 %)
3 diff
(99.4 %id)
NM_001126340.1   .a 14 to 10782 1 to 10769 exact RefSeq,   10769/10769
(100 %)
0 diff
(100 %id)
DA817886   .a 14 to 571 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
CN366875 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 22 to 734 1 to 712       712/712
(100 %)
2 diff
(99.8 %id)
DA008601 adipose .a 35 to 505 2 to 473   capped   472/472
(100 %)
3 diff
(99.4 %id)
AK056497   .a 35 to 2677 1 to 2638 exact available from FLJ,   2638/2638
(100 %)
7 diff
(99.8 %id)
DA742785   .a 38 to 502 2 to 462   capped   461/461
(100 %)
8 diff
(98.3 %id)
CN366869 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 39 to 651 1 to 610       610/610
(100 %)
5 diff
(99.2 %id)
BF939788 brain, glioblastoma (pooled) .a 40 to 523 484 to 1       484/484
(100 %)
1 diff
(99.8 %id)
BE313823 brain, neuroblastoma .a 51 to 669 1 to 619       619/667
(92 %)
8 diff
(98.9 %id)
DA032180   .a 57 to 586 2 to 532   capped   531/531
(100 %)
2 diff
(99.7 %id)
DA620753   .a 57 to 654 2 to 601   capped   600/600
(100 %)
2 diff
(99.7 %id)
DA654406   .a 57 to 601 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
DA159628 amygdala .a 58 to 614 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA202147 brain .a 58 to 644 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
DA441803 tongue, tumor tissue .a 58 to 626 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA883219   .a 58 to 583 2 to 527   capped   526/526
(100 %)
0 diff
(100 %id)
DA482709   .a 60 to 628 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
AI497633 anaplastic oligodendroglioma, brain .a 63 to 525 462 to 1       462/464
(99 %)
1 diff
(99.8 %id)
AI675155 anaplastic oligodendroglioma, brain .a 64 to 507 444 to 1       444/444
(100 %)
0 diff
(100 %id)
AI554664 anaplastic oligodendroglioma, brain .a 64 to 507 444 to 1       444/444
(100 %)
0 diff
(100 %id)
DB174614 kidney, tumor tissue .a 66 to 635 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA938105 Spleen .a 67 to 645 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
AA838743 parathyroid gland, parathyroid tumor .a 70 to 453 384 to 1       384/384
(100 %)
2 diff
(99.5 %id)
AA283821 germinal center B cell .a 71 to 521 453 to 4       450/453
(99 %)
2 diff
(99.6 %id)
DA341244 substantia nigra .a 73 to 623 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
AI475881 B-cell, chronic lymphotic leukemia .a 79 to 525 447 to 1       447/447
(100 %)
1 diff
(99.8 %id)
DA816759   .a 80 to 583 2 to 505   capped   504/504
(100 %)
1 diff
(99.9 %id)
DA702731   .a 83 to 578 2 to 497   capped   496/496
(100 %)
2 diff
(99.6 %id)
DA715297   .a 83 to 601 2 to 520   capped   519/519
(100 %)
1 diff
(99.9 %id)
BP255865 Kidney .a 84 to 652 1 to 569       569/569
(100 %)
3 diff
(99.5 %id)
BP280184   .a 84 to 666 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DA703085   .a 84 to 524 2 to 442   capped   441/441
(100 %)
1 diff
(99.8 %id)
DA047273   .a 85 to 656 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
DA092268 cerebellum .a 85 to 651 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA200184 brain .a 85 to 621 2 to 538   capped   537/537
(100 %)
2 diff
(99.7 %id)
DA574451   .a 85 to 630 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA576385   .a 85 to 644 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA716134   .a 85 to 583 2 to 500   capped   499/499
(100 %)
1 diff
(99.8 %id)
DA391474 thalamus .a 87 to 601 2 to 516   capped   515/515
(100 %)
2 diff
(99.7 %id)
DA393630 thalamus .a 87 to 658 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
BM011280 brain, neuroblastoma, cell line .a 92 to 810 1 to 718       718/721
(99 %)
7 diff
(99.1 %id)
TI_59380438   .a 93 to 810 59 to 775       717/720
(99 %)
6 diff
(99.2 %id)
AI475633 B-cell, chronic lymphotic leukemia .a 96 to 507 412 to 1       412/412
(100 %)
4 diff
(99.1 %id)
AI475736 B-cell, chronic lymphotic leukemia .a 96 to 507 412 to 1       412/412
(100 %)
2 diff
(99.6 %id)
BG333959 melanotic melanoma, skin .a 101 to 850 1 to 745   tiling clone,   745/749
(99 %)
16 diff
(97.9 %id)
BG334318 melanotic melanoma, skin .a 101 to 961 1 to 862       862/896
(96 %)
38 diff
(95.8 %id)
CN366868 embryonic stem cells, cell lines H1, H7, andH9 .a 103 to 688 1 to 587       587/587
(100 %)
4 diff
(99.4 %id)
AI708731 aorta .a 117 to 525 409 to 1       409/409
(100 %)
2 diff
(99.6 %id)
AA716471 heart .a 123 to 521 403 to 4       400/403
(99 %)
1 diff
(99.8 %id)
AA917765 adenocarcinoma, colon .a 129 to 472 343 to 1       343/343
(100 %)
3 diff
(99.2 %id)
CN366872 embryonic stem cells, cell lines H1, H7, andH9 .a 134 to 691 1 to 558       558/558
(100 %)
0 diff
(100 %id)
AI066649 senescent fibroblast .a 136 to 525 390 to 1       390/390
(100 %)
0 diff
(100 %id)
AW044192 pooled .a 142 to 525 384 to 1       384/384
(100 %)
0 diff
(100 %id)
AI498112 anaplastic oligodendroglioma, brain .a 145 to 525 382 to 2       381/382
(99 %)
0 diff
(100 %id)
DA578961   .a 154 to 708 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
AI569823 Kidney .a 158 to 525 368 to 1       368/368
(100 %)
0 diff
(100 %id)
AA928137 pooled .a 169 to 523 356 to 2       355/356
(99 %)
2 diff
(99.5 %id)
AW592376 pooled .a 169 to 525 357 to 1       357/357
(100 %)
0 diff
(100 %id)
AI038477 parathyroid gland, parathyroid tumor .a 185 to 470 286 to 1       286/286
(100 %)
0 diff
(100 %id)
BC069270 Brain, astrocytoma, grade IV .a 201 to 2677 1 to 2477 exact available from MGC, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 2477/2477
(100 %)
5 diff
(99.8 %id)
BE794414 lung, small cell carcinoma .a 220 to 971 1 to 746       746/928
(80 %)
9 diff
(99.1 %id)
DA999086 breast, tumor tissue .a 283 to 821 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
BX475379   .a 328 to 989 1 to 660       660/660
(100 %)
3 diff
(99.6 %id)
BQ672263 epidermoid carcinoma, cell line, salivary gland .a 344 to 1175 1 to 851       851/897
(94 %)
35 diff
(96.1 %id)
AA766538 germinal center B cell .a 345 to 439 95 to 1       95/95
(100 %)
0 diff
(100 %id)
BI160575 epithelioid carcinoma cell line, Pancreas .a 349 to 1134 1 to 784       784/785
(99 %)
8 diff
(99.0 %id)
BG752001 eye, normal pigmented retinal epithelium .a 359 to 970 1 to 611       611/611
(100 %)
1 diff
(99.9 %id)
BG753106 eye, normal pigmented retinal epithelium .a 359 to 1185 1 to 834       834/834
(100 %)
13 diff
(98.5 %id)
BE263122 brain, neuroblastoma .a 363 to 1180 1 to 810       810/943
(85 %)
35 diff
(96.3 %id)
DA410175 thalamus .a 369 to 920 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
AI758348 Kidney .a 374 to 525 152 to 1       152/152
(100 %)
0 diff
(100 %id)
BQ957218 large cell carcinoma, lung .a 401 to 1333 32 to 979       948/980
(96 %)
43 diff
(95.7 %id)
BP265275 thyroid .a 422 to 1012 1 to 590       590/590
(100 %)
2 diff
(99.7 %id)
BP266093 thyroid .a 422 to 1007 1 to 585       585/585
(100 %)
3 diff
(99.5 %id)
AI440498 B-cell, chronic lymphotic leukemia .a 518 to 983 1 to 466     Submitted on the opposite strand 466/466
(100 %)
1 diff
(99.8 %id)
TI_154133353   .a 518 to 1131 53 to 671     Submitted on the opposite strand 619/1037
(59 %)
13 diff
(98.8 %id)
TI_154136602   .a 518 to 1357 22 to 858     Submitted on the opposite strand 837/1093
(76 %)
32 diff
(97.1 %id)
AW206309   .a 519 to 1007 1 to 489     Submitted on the opposite strand 489/489
(100 %)
3 diff
(99.4 %id)
AW575788 lymph .a 519 to 1009 1 to 491     Submitted on the opposite strand 491/491
(100 %)
1 diff
(99.8 %id)
BG056679 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .a 527 to 1014 1 to 488     Submitted on the opposite strand 488/488
(100 %)
1 diff
(99.8 %id)
DB190198 lung, tumor tissue .a 528 to 1109 2 to 585   capped   584/584
(100 %)
2 diff
(99.7 %id)
DB246076 uterus, tumor tissue .a 532 to 1101 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
AI494558 B-cell, chronic lymphotic leukemia .a 536 to 877 1 to 342     Submitted on the opposite strand 342/342
(100 %)
0 diff
(100 %id)
BE674677 B-cell, chronic lymphotic leukemia .a 548 to 878 1 to 331     Submitted on the opposite strand 331/331
(100 %)
0 diff
(100 %id)
AA745483 germinal center B cell .a 549 to 668 1 to 119     Submitted on the opposite strand 119/119
(100 %)
1 diff
(99.2 %id)
AI381425 B-cell, chronic lymphotic leukemia .a 553 to 983 1 to 430     Submitted on the opposite strand 430/432
(99 %)
2 diff
(99.6 %id)
AI760535 B-cell, chronic lymphotic leukemia .a 553 to 873 1 to 321     Submitted on the opposite strand 321/321
(100 %)
0 diff
(100 %id)
BP288754 lung .a 574 to 1151 1 to 578       578/581
(99 %)
1 diff
(99.9 %id)
BP254335 Kidney .a 596 to 1174 1 to 579       579/582
(99 %)
1 diff
(99.9 %id)
BC009183 Lymph, Burkitt lymphoma .a 623 to 2677 1 to 2055   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 2055/2055
(100 %)
2 diff
(100.0 %id)
BE559887 Burkitt lymphoma, lymph .a 642 to 1396 1 to 750   available from MGC,   750/838
(89 %)
18 diff
(97.9 %id)
CT003467 T-Lymphocytes .a 646 to 1207 1 to 562       562/565
(99 %)
1 diff
(99.9 %id)
BX370578   .a 655 to 1552 902 to 5     Submitted on the opposite strand 898/902
(99 %)
0 diff
(100 %id)
CA951030 Pancreas, Purified pancreatic islet .a 702 to 1054 1 to 353       353/353
(100 %)
0 diff
(100 %id)
CF137802 lymph .a 774 to 1153 7 to 386       380/386
(98 %)
2 diff
(99.5 %id)
BG765443 melanotic melanoma, high MDR (cell line), skin .a 781 to 1242 1 to 464       464/464
(100 %)
3 diff
(99.4 %id)
BG747046 adenocarcinoma cell line, colon .a 812 to 1536 1 to 725       725/725
(100 %)
3 diff
(99.6 %id)
BQ052971 blood, natural killer cells, cell line .a 816 to 1656 1 to 859       859/1081
(79 %)
31 diff
(97.2 %id)
AF258552   .a 817 to 2677 1 to 1862   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 1862/1862
(100 %)
5 diff
(99.8 %id)
BQ054350 blood, natural killer cells, cell line .a 819 to 1714 1 to 912       912/1058
(86 %)
8 diff
(99.3 %id)
BP255048 Kidney .a 855 to 1428 1 to 574       574/574
(100 %)
1 diff
(99.9 %id)
DA913350   .a 868 to 1438 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA088406 cerebellum .a 879 to 1440 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
Z45891 brain, total brain .a 889 to 1169 1 to 280       280/280
(100 %)
2 diff
(99.3 %id)
BG759643 B-cells, primary B-cells from tonsils (cell line) .a 927 to 1740 1 to 813       813/813
(100 %)
8 diff
(99.1 %id)
TI_154188580   .a 928 to 1680 120 to 870       751/935
(80 %)
37 diff
(96.1 %id)
BF802119 colon_ins .a 1003 to 1289 287 to 1     Submitted on the opposite strand 287/287
(100 %)
1 diff
(99.7 %id)
CD675428 eye, lens .a 1020 to 1689 675 to 6     Submitted on the opposite strand 670/675
(99 %)
0 diff
(100 %id)
BG824475 adenocarcinoma cell line, colon .a 1049 to 1867 1 to 812       812/843
(96 %)
34 diff
(96.0 %id)
Y10777   .a 1051 to 1752 16 to 718       703/718
(97 %)
6 diff
(99.2 %id)
BP252918 Kidney .a 1077 to 1662 1 to 586       586/586
(100 %)
1 diff
(99.9 %id)
BM555502 duodenal adenocarcinoma, cell line, small intestine .a 1081 to 2059 14 to 1009       996/1023
(97 %)
31 diff
(97.0 %id)
BE207007 lung, small cell carcinoma .a 1086 to 1555 1 to 470       470/470
(100 %)
0 diff
(100 %id)
BP252961 Kidney .a 1089 to 1668 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
BG756954 B-cells, primary B-cells from tonsils (cell line) .a 1093 to 1857 1 to 765       765/851
(89 %)
8 diff
(99.1 %id)
Z41515 brain, total brain .a 2089 to 2347 259 to 1       259/259
(100 %)
0 diff
(100 %id)
DB324799   .a 2156 to 2677 522 to 1       522/522
(100 %)
2 diff
(99.7 %id)
AW732205 lung, small cell carcinoma .a 2362 to 2693 332 to 1   tiling clone,   332/332
(100 %)
1 diff
(99.7 %id)
BC016797 Bone marrow, acute myelogenous leukemia .a 2863 to 3922 4 to 1063   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 1060/1060
(100 %)
1 diff
(100.0 %id)
BG166308 hypernephroma, cell line, Kidney .a 2936 to 3678 1 to 739       739/742
(99 %)
8 diff
(99.0 %id)
TI_154160860   .a 3148 to 3699 655 to 104   AAA Submitted on the opposite strand 552/552
(100 %)
10 diff
(98.2 %id)
AI096442 brain, glioblastoma (pooled) .a 3206 to 3693 489 to 2       488/489
(99 %)
0 diff
(100 %id)
AW504623 lymph .a 3287 to 3699 439 to 27   AAA Submitted on the opposite strand 413/413
(100 %)
0 diff
(100 %id)
BM480380 duodenal adenocarcinoma, cell line, small intestine .a 3287 to 3699 1 to 413   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 413/413
(100 %)
4 diff
(99.1 %id)
BM480375 duodenal adenocarcinoma, cell line, small intestine .a 3288 to 3699 1 to 412   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 412/412
(100 %)
0 diff
(100 %id)
CF137132 lymph .a 3688 to 4233 1 to 546       546/546
(100 %)
5 diff
(99.1 %id)
TI_154166456   .a 3694 to 4406 89 to 803   tiling clone,   715/846
(84 %)
11 diff
(98.7 %id)
AA578832 lung, lung tumor .a 3727 to 4160 432 to 1       432/432
(100 %)
1 diff
(99.8 %id)
BU932805 mixed (pool of 40 RNAs) .a 3729 to 4161 1 to 433       433/433
(100 %)
4 diff
(99.1 %id)
BG912302 anaplastic oligodendroglioma with 1p/19qloss, brain .a 4288 to 5083 1 to 797   tiling clone,   797/797
(100 %)
3 diff
(99.7 %id)
BG912430 anaplastic oligodendroglioma with 1p/19qloss, brain .a 4289 to 5175 1 to 888       888/921
(96 %)
34 diff
(96.4 %id)
CN429790 embryonic stem cells, DMSO-treated H9 cellline .a 4401 to 4994 1 to 594       594/594
(100 %)
1 diff
(99.9 %id)
TI_154159859   .a 4427 to 5119 771 to 88     Submitted on the opposite strand 684/684
(100 %)
65 diff
(90.5 %id)
TI_154151126   .a 4580 to 5177 683 to 86     Submitted on the opposite strand 598/660
(90 %)
26 diff
(96.1 %id)
AI457596 pooled .a 4650 to 5162 513 to 1       513/513
(100 %)
0 diff
(100 %id)
BQ279062 adenocarcinoma, cell line, breast .a 4664 to 5177 525 to 10   tiling clone, Submitted on the opposite strand 516/1220
(42 %)
0 diff
(100 %id)
TI_154164682   .a 4694 to 5576 966 to 91     Submitted on the opposite strand 876/912
(96 %)
0 diff
(100 %id)
AW503872 lymph .a 4711 to 5121 416 to 6     Submitted on the opposite strand 411/416
(98 %)
0 diff
(100 %id)
BU430014 lymph .a 4714 to 5177 471 to 8     Submitted on the opposite strand 464/471
(98 %)
0 diff
(100 %id)
AI079196 brain, glioblastoma (pooled) .a 4808 to 5114 306 to 1       306/306
(100 %)
1 diff
(99.7 %id)
CF135969 lymph .a 4845 to 5576 755 to 22   tiling clone, Submitted on the opposite strand 734/755
(97 %)
0 diff
(100 %id)
BQ001045 lung, Metastatic Chondrosarcoma .a 5150 to 5573 20 to 446   AAA Submitted on the opposite strand 427/446
(95 %)
6 diff
(98.7 %id)
AI694724 carcinoid, lung .a 5210 to 5568 359 to 1       359/359
(100 %)
1 diff
(99.8 %id)
BE467434 carcinoid, lung .a 5210 to 5568 359 to 1       359/359
(100 %)
1 diff
(99.8 %id)
BE550657 carcinoid, lung .a 5210 to 5568 359 to 1       359/359
(100 %)
1 diff
(99.8 %id)
AA723108 heart .a 5211 to 5570 360 to 1       360/360
(100 %)
1 diff
(99.8 %id)
BE669600 carcinoid, lung .a 5211 to 5570 362 to 3       360/362
(99 %)
0 diff
(100 %id)
BF223626 carcinoid, lung .a 5211 to 5570 362 to 3       360/362
(99 %)
0 diff
(100 %id)
AA995322 2 pooled tumors (clear cell type), Kidney .a 5265 to 5570 308 to 3       306/308
(99 %)
0 diff
(100 %id)
CK904900 Islets of Langerhans, Pancreas .a 5325 to 5573 1 to 249   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 249/251
(99 %)
1 diff
(99.7 %id)
BM055311 Islets of Langerhans, Pancreas .a 5341 to 5573 1 to 233   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 233/233
(100 %)
0 diff
(100 %id)
BM055032 Islets of Langerhans, Pancreas .a 5371 to 5573 217 to 15   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 203/203
(100 %)
0 diff
(100 %id)
C21528   .a 5483 to 5569 1 to 87       87/87
(100 %)
0 diff
(100 %id)
AK128753 cerebellum .a 5570 to 10782 1 to 5213   tiling clone, available from FLJ,   5213/5213
(100 %)
62 diff
(98.9 %id)
DA123717 cerebellum .a 5571 to 6115 2 to 548   capped   547/548
(99 %)
3 diff
(99.5 %id)
DA114171 cerebellum .a 6464 to 6942 2 to 480   tiling clone, capped   479/479
(100 %)
5 diff
(99.0 %id)
BF923186 nervous_tumor .a 7305 to 7727 1 to 424       424/424
(100 %)
2 diff
(99.6 %id)
BQ018085 Fibrosarcoma .a 8460 to 9158 713 to 15   tiling clone, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 699/699
(100 %)
2 diff
(99.8 %id)
DB517275.
matches multiple genes
testis .a 10206 to 10637 432 to 1     also hits gene ALKBH4 432/432
(100 %)
1 diff
(99.8 %id)
DB300084 cerebellum .a 10217 to 10782 565 to 1   tiling clone,   565/565
(100 %)
1 diff
(99.9 %id)
DB300659 cerebellum .a 10292 to 10782 493 to 1       493/493
(100 %)
9 diff
(98.2 %id)
NM_032831.2   .b 1 to 10660 1 to 10660 exact RefSeq,   10660/10660
(100 %)
0 diff
(100 %id)
AK027639   .b 28 to 2555 1 to 2527 exact tiling clone, available from FLJ,   2527/2527
(100 %)
8 diff
(99.7 %id)
DA735848   .b 29 to 763 2 to 733   capped   732/732
(100 %)
5 diff
(99.4 %id)
DA943379 Spleen .b 53 to 603 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
TI_157598444   .b 68 to 416 384 to 35       350/1056
(33 %)
0 diff
(100 %id)
DA685359   .b 72 to 617 2 to 549   capped   548/548
(100 %)
4 diff
(99.3 %id)
DA961802 Spleen .b 72 to 622 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DB110431 thymus .b 72 to 599 2 to 529   capped   528/528
(100 %)
0 diff
(100 %id)
DB368204   .b 2008 to 2555 547 to 1       547/553
(98 %)
19 diff
(96.6 %id)
AK124753 brain .c-u 1 to 3757 1 to 3758 H2V P3W V55L L72F R73E ... tiling clone, available from FLJ,   3758/3758
(100 %)
11 diff
(99.8 %id)
N20643 melanocyte .c-u 217 to 651 1 to 435     Submitted on the opposite strand 435/435
(100 %)
3 diff
(99.4 %id)
N29015 melanocyte .c-u 331 to 791 463 to 1     Submitted on the opposite strand 463/464
(99 %)
6 diff
(98.8 %id)
AI214107 astrocytoma, brain .c-u 377 to 787 411 to 1       411/411
(100 %)
2 diff
(99.6 %id)
BQ370889 placenta_normal .c-u 437 to 744 315 to 10   tiling clone,   306/315
(97 %)
0 diff
(100 %id)
AK097289 Spleen .c-u 715 to 3749 1 to 3035   tiling clone, available from FLJ,   3035/3035
(100 %)
7 diff
(99.8 %id)
DA950866 Spleen .c-u 716 to 1282 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DA091421 cerebellum .c-u 1551 to 2086 2 to 538   tiling clone, capped   537/537
(100 %)
2 diff
(99.7 %id)
BE735621 adenocarcinoma, Pancreas .c-u 2481 to 3213 1 to 731       731/930
(78 %)
27 diff
(97.1 %id)
BG340195 leiomyosarcoma cell line, uterus .c-u 2486 to 3220 1 to 742       742/838
(88 %)
34 diff
(96.0 %id)
BM720263 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c-u 2504 to 2973 1 to 470       470/470
(100 %)
0 diff
(100 %id)
BM561231 duodenal adenocarcinoma, cell line, small intestine .c-u 2573 to 3516 1 to 945       945/974
(97 %)
26 diff
(97.4 %id)
CA866559 Pancreas, Purified pancreatic islet .c-u 2580 to 3099 1 to 520       520/520
(100 %)
0 diff
(100 %id)
BF858187 prostate_tumor .c-u 2636 to 2893 1 to 258       258/258
(100 %)
4 diff
(98.5 %id)
BM507312 insulinoma, Pancreas .c-u 2773 to 3250 1 to 478       478/478
(100 %)
5 diff
(99.0 %id)
BG150331 carcinoid, lung .c-u 2802 to 3130 4 to 332     Submitted on the opposite strand 329/332
(99 %)
6 diff
(98.2 %id)
BG831408 epithelioid carcinoma cell line, Pancreas .c-u 2814 to 3746 1 to 929   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 929/932
(99 %)
38 diff
(96.0 %id)
CR980244 T-Lymphocytes .c-u 2830 to 3631 1 to 804       804/804
(100 %)
6 diff
(99.3 %id)
BI046369 prostate_normal .c-u 2838 to 3305 1 to 468       468/468
(100 %)
13 diff
(97.3 %id)
CR602187 Neuroblastoma Cot 50-normalized .c-u 2857 to 3746 1 to 890   tiling clone,   890/890
(100 %)
0 diff
(100 %id)
BQ669147 epidermoid carcinoma, cell line, salivary gland .c-u 2860 to 3736 1 to 890       890/905
(98 %)
23 diff
(97.5 %id)
BX355404 Neuroblastoma Cot 50-normalized .c-u 2864 to 3746 1 to 880       880/880
(100 %)
19 diff
(97.9 %id)
BQ881414 brain, neuroblastoma, cell line .c-u 2890 to 3568 1 to 681       681/823
(82 %)
15 diff
(98.2 %id)
BM785276 myeloma .c-u 2901 to 3511 1 to 611       611/611
(100 %)
2 diff
(99.7 %id)
BU183584 melanotic melanoma, skin .c-u 2904 to 3705 8 to 812       805/889
(90 %)
16 diff
(98.3 %id)
BF851979 lung_normal .c-u 2909 to 3415 1 to 510       510/510
(100 %)
11 diff
(97.9 %id)
BF852193 lung_normal .c-u 2909 to 3472 1 to 565       565/566
(99 %)
14 diff
(97.6 %id)
BF852199 lung_normal .c-u 2909 to 3447 1 to 539       539/539
(100 %)
6 diff
(98.9 %id)
BF852822 lung_normal .c-u 2909 to 3391 1 to 488       488/490
(99 %)
14 diff
(97.2 %id)
BF858188 prostate_tumor .c-u 2909 to 3087 1 to 178       178/178
(100 %)
2 diff
(98.9 %id)
BI046168 prostate_normal .c-u 2909 to 3305 1 to 401       401/401
(100 %)
9 diff
(97.8 %id)
BI046254 prostate_normal .c-u 2909 to 3493 1 to 584       584/616
(94 %)
13 diff
(97.9 %id)
BI046313 prostate_normal .c-u 2909 to 3305 1 to 397       397/397
(100 %)
1 diff
(99.8 %id)
BI046390 prostate_normal .c-u 2909 to 3476 1 to 568       568/568
(100 %)
6 diff
(99.0 %id)
BI046789 prostate_normal .c-u 2909 to 3417 1 to 511       511/511
(100 %)
16 diff
(96.9 %id)
BI046842 prostate_normal .c-u 2909 to 3476 1 to 568       568/569
(99 %)
9 diff
(98.5 %id)
BQ371742 prostate_normal .c-u 2909 to 3441 1 to 534       534/534
(100 %)
23 diff
(95.7 %id)
CK905579 insulinoma, Pancreas .c-u 2910 to 3206 1 to 297       297/297
(100 %)
1 diff
(99.7 %id)
BM716501 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c-u 2933 to 3544 1 to 613       613/613
(100 %)
3 diff
(99.6 %id)
CF454535 peripheral nervous system .c-u 2975 to 3705 18 to 747       730/747
(97 %)
6 diff
(99.2 %id)
BF852849 lung_normal .c-u 3000 to 3535 1 to 540       540/540
(100 %)
15 diff
(97.3 %id)
BG769249 melanotic melanoma, high MDR (cell line), skin .c-u 3011 to 3707 1 to 693       693/693
(100 %)
8 diff
(98.9 %id)
BQ445865 Knee, Osteoarthritic Cartilage .c-u 3012 to 3749 752 to 19   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 734/734
(100 %)
7 diff
(99.1 %id)
CB159918 Liver .c-u 3038 to 3606 1 to 569       569/569
(100 %)
1 diff
(99.9 %id)
TI_149278125   .c-u 3042 to 3751 799 to 91   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 709/710
(99 %)
2 diff
(99.8 %id)
BG994490 head_neck .c-u 3108 to 3305 1 to 198       198/198
(100 %)
2 diff
(99.0 %id)
BU678232 lung .c-u 3124 to 3751 644 to 17   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 628/628
(100 %)
1 diff
(99.9 %id)
BM565573 insulinoma, Pancreas .c-u 3150 to 3749 615 to 16   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 600/600
(100 %)
1 diff
(99.9 %id)
AA534224 adrenal adenoma, adrenal gland .c-u 3152 to 3750 601 to 5       597/607
(98 %)
0 diff
(100 %id)
CA866825 Pancreas, Purified pancreatic islet .c-u 3154 to 3766 617 to 5   tiling clone,   613/617
(99 %)
0 diff
(100 %id)
W72542 heart .c-u 3184 to 3749 569 to 1       569/570
(99 %)
9 diff
(98.5 %id)
BQ016029 lung, Metastatic Chondrosarcoma .c-u 3193 to 3757 583 to 19   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 565/565
(100 %)
2 diff
(99.7 %id)
DB333753 Spleen .c-u 3207 to 3749 545 to 1       545/545
(100 %)
2 diff
(99.7 %id)
DB298317 cerebellum .c-u 3213 to 3749 537 to 1       537/537
(100 %)
0 diff
(100 %id)
BG057658 blood, lymphocyte .c-u 3215 to 3749 535 to 1       535/535
(100 %)
0 diff
(100 %id)
AI740517 pooled .c-u 3239 to 3757 529 to 11   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 519/519
(100 %)
2 diff
(99.7 %id)
BG756396 B-cells, primary B-cells from tonsils (cell line) .c-u 3252 to 3749 1 to 497   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 497/497
(100 %)
1 diff
(99.8 %id)
BG760122 B-cells, primary B-cells from tonsils (cell line) .c-u 3252 to 3750 1 to 498       498/540
(92 %)
3 diff
(99.5 %id)
AI798745 pooled .c-u 3255 to 3746 507 to 15       493/507
(97 %)
5 diff
(99.1 %id)
BF110951 carcinoid, lung .c-u 3255 to 3760 507 to 1       507/507
(100 %)
3 diff
(99.5 %id)
AI934973 pooled .c-u 3259 to 3750 497 to 6       492/497
(98 %)
0 diff
(100 %id)
AW008040 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c-u 3267 to 3750 487 to 3       485/487
(99 %)
0 diff
(100 %id)
AI808564 pooled .c-u 3270 to 3750 484 to 4       481/484
(99 %)
0 diff
(100 %id)
AA494456 colon .c-u 3293 to 3750 459 to 2       458/459
(99 %)
0 diff
(100 %id)
BF823568 kidney_tumor .c-u 3295 to 3586 8 to 299       292/299
(97 %)
6 diff
(98.0 %id)
BI006357 kidney_tumor .c-u 3295 to 3610 30 to 344       315/344
(91 %)
6 diff
(98.3 %id)
BI007722 kidney_tumor .c-u 3300 to 3610 11 to 322       312/322
(96 %)
6 diff
(98.2 %id)
AI628098 Kidney .c-u 3303 to 3749 461 to 15   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 447/447
(100 %)
0 diff
(100 %id)
BF823552 kidney_tumor .c-u 3305 to 3587 1 to 283       283/283
(100 %)
0 diff
(100 %id)
BF823553 kidney_tumor .c-u 3305 to 3585 1 to 281       281/281
(100 %)
1 diff
(99.7 %id)
BF823554 kidney_tumor .c-u 3305 to 3584 1 to 280       280/280
(100 %)
0 diff
(100 %id)
BF823555 kidney_tumor .c-u 3305 to 3587 1 to 283       283/283
(100 %)
0 diff
(100 %id)
BF823556 kidney_tumor .c-u 3305 to 3582 1 to 279       279/279
(100 %)
1 diff
(99.7 %id)
BF823557 kidney_tumor .c-u 3305 to 3584 1 to 280       280/280
(100 %)
1 diff
(99.7 %id)
BF823561 kidney_tumor .c-u 3305 to 3585 1 to 281       281/281
(100 %)
0 diff
(100 %id)
BF823562 kidney_tumor .c-u 3305 to 3588 1 to 284       284/284
(100 %)
0 diff
(100 %id)
BF823565 kidney_tumor .c-u 3305 to 3586 1 to 282       282/282
(100 %)
1 diff
(99.7 %id)
BF823571 kidney_tumor .c-u 3305 to 3584 1 to 280       280/280
(100 %)
1 diff
(99.7 %id)
BF823573 kidney_tumor .c-u 3305 to 3584 1 to 280       280/280
(100 %)
0 diff
(100 %id)
BF823574 kidney_tumor .c-u 3305 to 3555 1 to 251       251/251
(100 %)
0 diff
(100 %id)
BI006362 kidney_tumor .c-u 3305 to 3610 1 to 306       306/306
(100 %)
2 diff
(99.4 %id)
BQ327676 kidney_tumor .c-u 3305 to 3498 1 to 194       194/194
(100 %)
0 diff
(100 %id)
BQ327762 kidney_tumor .c-u 3320 to 3610 1 to 291       291/291
(100 %)
2 diff
(99.4 %id)
BG988083 head_neck .c-u 3323 to 3620 1 to 297       297/299
(99 %)
9 diff
(97.0 %id)
BG994458 head_neck .c-u 3323 to 3620 1 to 297       297/298
(99 %)
7 diff
(97.7 %id)
BI006344 kidney_tumor .c-u 3323 to 3610 1 to 288       288/288
(100 %)
0 diff
(100 %id)
BI006345 kidney_tumor .c-u 3323 to 3610 1 to 288       288/288
(100 %)
0 diff
(100 %id)
BI006346 kidney_tumor .c-u 3323 to 3610 1 to 288       288/288
(100 %)
0 diff
(100 %id)
BI006347 kidney_tumor .c-u 3323 to 3610 1 to 288       288/288
(100 %)
0 diff
(100 %id)
BI006348 kidney_tumor .c-u 3323 to 3610 1 to 288       288/288
(100 %)
1 diff
(99.7 %id)
BI006349 kidney_tumor .c-u 3323 to 3610 1 to 287       287/287
(100 %)
1 diff
(99.7 %id)
BI006350 kidney_tumor .c-u 3323 to 3610 1 to 288       288/288
(100 %)
1 diff
(99.7 %id)
BI006351 kidney_tumor .c-u 3323 to 3610 1 to 288       288/288
(100 %)
1 diff
(99.7 %id)
BI006352 kidney_tumor .c-u 3323 to 3610 1 to 288       288/288
(100 %)
0 diff
(100 %id)
BI006353 kidney_tumor .c-u 3323 to 3610 1 to 288       288/288
(100 %)
1 diff
(99.7 %id)
BI006354 kidney_tumor .c-u 3323 to 3610 1 to 288       288/288
(100 %)
1 diff
(99.7 %id)
BI006355 kidney_tumor .c-u 3323 to 3610 1 to 288       288/288
(100 %)
0 diff
(100 %id)
BI006358 kidney_tumor .c-u 3323 to 3610 1 to 288       288/288
(100 %)
0 diff
(100 %id)
BI006359 kidney_tumor .c-u 3323 to 3610 1 to 288       288/288
(100 %)
0 diff
(100 %id)
BI006360 kidney_tumor .c-u 3323 to 3610 1 to 288       288/288
(100 %)
0 diff
(100 %id)
BI006361 kidney_tumor .c-u 3323 to 3610 1 to 288       288/288
(100 %)
1 diff
(99.7 %id)
BI006903 kidney_tumor .c-u 3323 to 3582 1 to 260       260/260
(100 %)
0 diff
(100 %id)
BI006905 kidney_tumor .c-u 3323 to 3584 1 to 262       262/262
(100 %)
1 diff
(99.7 %id)
BI007714 kidney_tumor .c-u 3323 to 3610 1 to 288       288/288
(100 %)
6 diff
(98.0 %id)
BI007716 kidney_tumor .c-u 3323 to 3610 1 to 288       288/288
(100 %)
0 diff
(100 %id)
BI007720 kidney_tumor .c-u 3323 to 3610 1 to 288       288/288
(100 %)
1 diff
(99.7 %id)
BI007723 kidney_tumor .c-u 3323 to 3610 1 to 289       289/289
(100 %)
6 diff
(98.0 %id)
BI007725 kidney_tumor .c-u 3323 to 3610 1 to 288       288/288
(100 %)
2 diff
(99.4 %id)
BI007726 kidney_tumor .c-u 3323 to 3610 1 to 288       288/288
(100 %)
0 diff
(100 %id)
BQ327763 kidney_tumor .c-u 3323 to 3610 1 to 288       288/288
(100 %)
6 diff
(98.0 %id)
BQ355778 head_neck .c-u 3323 to 3610 1 to 289       289/289
(100 %)
5 diff
(98.3 %id)
AI034211 parathyroid gland, parathyroid tumor .c-u 3323 to 3757 445 to 11   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 435/435
(100 %)
4 diff
(99.1 %id)
BP250761 hippocampus .c-u 3332 to 3750 1 to 419       419/582
(71 %)
1 diff
(99.9 %id)
DB532718 hippocampus .c-u 3340 to 3762 1 to 424     Submitted on the opposite strand 424/426
(99 %)
3 diff
(99.3 %id)
F35431 pectoral muscle (after mastectomy) .c-u 3343 to 3663 1 to 321       321/321
(100 %)
0 diff
(100 %id)
AI953759 brain, three pooled meningiomas .c-u 3349 to 3749 423 to 23   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 401/401
(100 %)
2 diff
(99.6 %id)
AW198157 adenocarcinoma, Pancreas .c-u 3351 to 3746 399 to 4       396/399
(99 %)
0 diff
(100 %id)
AI268251 carcinoid, lung .c-u 3352 to 3763 412 to 1       412/412
(100 %)
1 diff
(99.8 %id)
FN058992 breast carcinoma .c-u 3356 to 3437 1 to 82       82/82
(100 %)
0 diff
(100 %id)
AI240144 pooled .c-u 3359 to 3750 395 to 4       392/395
(99 %)
0 diff
(100 %id)
AI540209 pooled .c-u 3359 to 3750 395 to 4       392/395
(99 %)
0 diff
(100 %id)
AI282119 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c-u 3363 to 3757 407 to 13   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 395/395
(100 %)
3 diff
(99.3 %id)
AW271744 Kidney .c-u 3364 to 3757 394 to 1       394/394
(100 %)
0 diff
(100 %id)
AI674519 Prostate .c-u 3366 to 3757 392 to 1       392/392
(100 %)
0 diff
(100 %id)
BF222198 Prostate .c-u 3366 to 3750 385 to 1       385/385
(100 %)
1 diff
(99.8 %id)
BF436786 Prostate .c-u 3366 to 3749 403 to 20   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 384/384
(100 %)
3 diff
(99.3 %id)
AI623180 pooled germ cell tumors .c-u 3371 to 3750 381 to 2       380/381
(99 %)
0 diff
(100 %id)
AI990359 pooled germ cell tumors .c-u 3371 to 3750 384 to 5       380/384
(98 %)
0 diff
(100 %id)
BG055898 anaplastic oligodendroglioma, brain .c-u 3442 to 3750 309 to 1       309/309
(100 %)
1 diff
(99.7 %id)
AI478254 Kidney .c-u 3455 to 3749 295 to 1       295/295
(100 %)
0 diff
(100 %id)
BX327721 Neuroblastoma Cot 50-normalized .c-u 3502 to 3746 1 to 242       242/242
(100 %)
6 diff
(97.6 %id)
AI864805 lymph node, lymphoma, follicular mixed small and largecell .c-u 3540 to 3764 229 to 2       228/229
(99 %)
0 diff
(100 %id)
AU185924 skin .c-u 3559 to 3748 1 to 190       190/190
(100 %)
0 diff
(100 %id)
FN156572 breast carcinoma .c-u 3655 to 3751 1 to 96       96/96
(100 %)
1 diff
(99.0 %id)
BG334189 melanotic melanoma, skin .d 1 to 674 1 to 666   tiling clone,   666/666
(100 %)
13 diff
(98.1 %id)
AA078606 placenta .d 313 to 591 279 to 1       279/294
(94 %)
3 diff
(99.0 %id)
AK298774   .d 364 to 1247 1 to 884   tiling clone,   884/884
(100 %)
1 diff
(99.9 %id)
BP231544 muscle .e 1 to 575 1 to 575   tiling clone,   575/577
(99 %)
1 diff
(99.9 %id)
DC406526 thymus .e 1 to 568 1 to 568       568/568
(100 %)
1 diff
(99.9 %id)
DC319877 brain .e 47 to 629 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DN996924 breast cancer, Mammary gland (cancer tissue) .e 511 to 1037 9 to 535   tiling clone,   527/535
(98 %)
6 diff
(98.9 %id)
AK294664 brain .f 1 to 904 1 to 904 exact tiling clone,   904/904
(100 %)
0 diff
(100 %id)
BX339248 Placenta Cot 25-normalized .g 1 to 734 1 to 735 E167X A168G S169I G170W T171N ... tiling clone,   735/735
(100 %)
5 diff
(99.4 %id)
NM_024653.3   .g 19 to 2199 1 to 2181 exact RefSeq,   2181/2181
(100 %)
1 diff
(100.0 %id)
DA913778   .g 20 to 578 2 to 561   capped   560/560
(100 %)
3 diff
(99.5 %id)
BP272034   .g 21 to 632 1 to 612 A5S A6V     612/612
(100 %)
3 diff
(99.6 %id)
DA697115   .g 21 to 597 2 to 578   capped   577/577
(100 %)
3 diff
(99.5 %id)
BP271893   .g 22 to 628 1 to 607 V9L K16R Q19*     607/607
(100 %)
10 diff
(98.4 %id)
BP357860 mammary gland .g 22 to 603 1 to 582       582/582
(100 %)
0 diff
(100 %id)
AK023964 thyroid gland .g 23 to 2197 1 to 2175 exact available from FLJ,   2175/2175
(100 %)
4 diff
(99.9 %id)
DA485376 brain .g 23 to 585 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA695251   .g 23 to 536 2 to 514   capped   513/516
(99 %)
8 diff
(98.5 %id)
DB122931 thymus .g 23 to 557 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
DA360550 subthalamic nucleus .g 24 to 579 2 to 558   capped   557/557
(100 %)
3 diff
(99.5 %id)
AU142109 thyroid gland .g 24 to 804 2 to 780 exact capped   779/779
(100 %)
6 diff
(99.3 %id)
DA052951   .g 25 to 615 2 to 593   capped   592/592
(100 %)
1 diff
(99.9 %id)
BP249675 Kidney .g 25 to 606 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP356624 mammary gland .g 25 to 450 1 to 426       426/436
(97 %)
1 diff
(99.8 %id)
BP356913 mammary gland .g 25 to 606 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP356953 mammary gland .g 25 to 605 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DA037941   .g 26 to 571 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA150443 amygdala .g 26 to 604 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
DA156857 amygdala .g 26 to 581 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
DA200087 brain .g 26 to 595 2 to 572   capped   571/571
(100 %)
4 diff
(99.3 %id)
DA557591   .g 26 to 591 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA627260 Kidney .g 26 to 568 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DA702714   .g 26 to 595 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA819479   .g 26 to 589 2 to 565   capped   564/564
(100 %)
3 diff
(99.5 %id)
DA870357 Prostate .g 26 to 582 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA911790   .g 26 to 579 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA946845 Spleen .g 26 to 592 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DB033332 testis .g 26 to 604 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
DB036122 testis .g 26 to 575 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DB122422 thymus .g 26 to 609 2 to 586   capped   585/585
(100 %)
1 diff
(99.9 %id)
DA147120 amygdala .g 28 to 585 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA595881 lung .g 29 to 324 2 to 298   capped   297/297
(100 %)
1 diff
(99.7 %id)
TI_57241092   .g 29 to 684 26 to 683 K16E E17R P18A Q19A T20D ...     658/683
(96 %)
7 diff
(99.0 %id)
BI818449 pooled brain, lung, testis .g 37 to 825 1 to 794 K16E E17R P18A Q19A T20D ...     794/794
(100 %)
14 diff
(98.3 %id)
BI913117 brain .g 37 to 684 1 to 650 K16E E17R P18A Q19A T20D ...     650/650
(100 %)
2 diff
(99.7 %id)
TI_57196228   .g 37 to 825 31 to 824 K16E E17R P18A Q19A T20D ...     794/824
(96 %)
18 diff
(97.9 %id)
BX421331 B cells (Ramos cell line) .g 38 to 1078 1 to 1039 H84X L85X F109V Q110S K111E ...     1039/1039
(100 %)
29 diff
(97.3 %id)
BU596524 mixed (pool of 40 RNAs) .g 38 to 814 1 to 782 S7A     782/782
(100 %)
8 diff
(99.0 %id)
DA628569 Kidney .g 38 to 569 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DA605133   .g 39 to 602 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
BC014298 Lung, small cell carcinoma .g 40 to 2182 1 to 2143 D106Y tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 2143/2143
(100 %)
3 diff
(99.9 %id)
AL711732 human skeletal muscle .g 40 to 629 1 to 591 S7A V9G R10A P11T P12T ...     591/591
(100 %)
4 diff
(99.4 %id)
BM473701 melanotic melanoma, skin .g 40 to 963 1 to 931 exact     931/1157
(80 %)
18 diff
(98.5 %id)
BX333361 Neuroblastoma Cot 25-normalized .g 41 to 750 1 to 709 T20X P24X P42X P57X P59X ...     709/709
(100 %)
1 diff
(99.9 %id)
AI299324 carcinoid, lung .g 41 to 479 1 to 439     Submitted on the opposite strand 439/439
(100 %)
2 diff
(99.6 %id)
DA281683 corpus callosum .g 43 to 581 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
DA254416 caudate nucleus .g 48 to 588 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DA749126   .g 48 to 597 2 to 553   capped   552/552
(100 %)
2 diff
(99.7 %id)
DA791158 brain .g 48 to 630 2 to 584 exact capped   583/583
(100 %)
0 diff
(100 %id)
BX394231 Neuroblastoma Cot 25-normalized .g 49 to 1061 1 to 1006 E167X A168G S169I G170W T171N ... fully sequenced,   1006/1006
(100 %)
10 diff
(99.1 %id)
CN259765 embryonic stem cells, DMSO-treated H9 cellline .g 50 to 552 1 to 503       503/503
(100 %)
0 diff
(100 %id)
DB119207 thymus .g 50 to 620 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
AL602914 human skeletal muscle .g 51 to 639 11 to 602 N116D S169L T171N E172R E173G ...     592/602
(98 %)
12 diff
(98.1 %id)
DA017155 adrenal gland .g 52 to 613 2 to 566   capped   565/565
(100 %)
5 diff
(99.2 %id)
DA173059 amygdala .g 52 to 619 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA301587 hippocampus .g 52 to 598 2 to 548   capped   547/547
(100 %)
2 diff
(99.7 %id)
DA342722 substantia nigra .g 52 to 632 2 to 582 exact capped   581/581
(100 %)
0 diff
(100 %id)
DA348717 substantia nigra .g 52 to 619 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA514553 brain .g 52 to 598 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA705541   .g 52 to 619 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA815735   .g 52 to 624 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA910856   .g 52 to 596 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA911395   .g 52 to 600 2 to 550   capped   549/549
(100 %)
2 diff
(99.7 %id)
DA979306 synovial membrane tissue from rheumatioidarthritis .g 52 to 624 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DB265566 uterus .g 52 to 631 2 to 581 exact capped   580/580
(100 %)
0 diff
(100 %id)
BP291999 lung .g 53 to 633 1 to 581 P61L     581/581
(100 %)
1 diff
(99.9 %id)
AL703416 human skeletal muscle .g 54 to 655 1 to 602 K150N     602/602
(100 %)
4 diff
(99.4 %id)
DA749277   .g 54 to 518 2 to 466   capped   465/465
(100 %)
0 diff
(100 %id)
DA285023 corpus callosum .g 55 to 607 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
BM836138 stomach .g 55 to 465 1 to 411       411/417
(98 %)
2 diff
(99.6 %id)
BP360100 thalamus .g 55 to 637 1 to 583 E176G     583/583
(100 %)
1 diff
(99.9 %id)
DB270064 uterus .g 55 to 604 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DA088369 cerebellum .g 56 to 588 2 to 535   capped   534/534
(100 %)
2 diff
(99.7 %id)
DA090544 cerebellum .g 56 to 620 2 to 570   capped   569/569
(100 %)
7 diff
(98.8 %id)
DA513069 brain .g 56 to 579 2 to 525   capped   524/524
(100 %)
0 diff
(100 %id)
DA562882 heart .g 56 to 622 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA626000 Kidney .g 56 to 604 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DA628063 Kidney .g 56 to 591 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
DA916380 small intestine .g 56 to 632 2 to 578 exact capped   577/577
(100 %)
0 diff
(100 %id)
DB013158 esophageal, tumor tissue .g 56 to 624 2 to 573   capped   572/572
(100 %)
4 diff
(99.4 %id)
DB242704 stomach, tumor tissue .g 56 to 616 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DB262694 uterus .g 56 to 588 2 to 534   capped   533/533
(100 %)
1 diff
(99.9 %id)
BI087198 cervix .g 57 to 871 1 to 821 K115N N116E K117*     821/821
(100 %)
20 diff
(97.6 %id)
BQ223930 large cell carcinoma, lung .g 57 to 783 1 to 731 exact     731/918
(79 %)
14 diff
(98.5 %id)
DA824069 pericardium .g 57 to 611 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA153617 amygdala .g 58 to 403 2 to 347   capped   346/346
(100 %)
0 diff
(100 %id)
DN995935 breast cancer, Mammary gland (cancer tissue) .g 58 to 664 10 to 616 exact     607/616
(98 %)
6 diff
(99.1 %id)
AI299332 carcinoid, lung .g 59 to 479 1 to 421     Submitted on the opposite strand 421/421
(100 %)
0 diff
(100 %id)
BE791028 lung, small cell carcinoma .g 59 to 920 1 to 856 E101A D106Y     856/1067
(80 %)
21 diff
(98.1 %id)
BQ643286 lymph, lymphoma, cell line .g 60 to 963 1 to 914 exact     914/932
(98 %)
10 diff
(99.0 %id)
DA956610 Spleen .g 62 to 608 2 to 552   capped   551/551
(100 %)
6 diff
(99.0 %id)
CD632182   .g 63 to 747 8 to 696 K135T E136R K137E K138R L139N ...     689/698
(98 %)
25 diff
(96.5 %id)
BG387706 embryonal carcinoma, cell line, testis .g 63 to 465 1 to 405       405/429
(94 %)
3 diff
(99.4 %id)
BQ879881 brain, neuroblastoma, cell line .g 63 to 973 1 to 913 E108*     913/914
(99 %)
7 diff
(99.3 %id)
DA369049 subthalamic nucleus .g 64 to 618 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
CR599339 B cells (Ramos cell line) .g 64 to 2149 1 to 2086 exact tiling clone,   2086/2086
(100 %)
0 diff
(100 %id)
AL560102 B cells (Ramos cell line), B cells from Burkitt lymphoma .g 64 to 1148 1 to 1082 exact fully sequenced,   1082/1082
(100 %)
13 diff
(98.8 %id)
TI_1948083619   .g 65 to 478 116 to 529       414/420
(98 %)
6 diff
(98.6 %id)
BP345583 synovial membrane .g 65 to 644 1 to 580 exact     580/580
(100 %)
0 diff
(100 %id)
DA148098 amygdala .g 66 to 552 2 to 488   capped   487/487
(100 %)
2 diff
(99.6 %id)
DA748067   .g 66 to 645 2 to 582 T181H M182H R184A capped   581/581
(100 %)
1 diff
(99.9 %id)
BP345525 synovial membrane .g 66 to 637 1 to 568 A5P A6P S7P S8R V9C ...     568/568
(100 %)
4 diff
(99.3 %id)
BE791075 lung, small cell carcinoma .g 73 to 921 10 to 843 S8R V9C R10D P11T P12E ...     834/848
(98 %)
39 diff
(95.5 %id)
CV028207 mixed .g 74 to 638 1 to 565 D106Y     565/629
(89 %)
7 diff
(98.9 %id)
BF527644 anaplastic oligodendroglioma with 1p/19qloss, brain .g 75 to 889 1 to 803       805/832
(96 %)
37 diff
(95.6 %id)
DA308407 hippocampus .g 86 to 645 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
AW138586   .g 107 to 465 385 to 27   AAA   359/368
(97 %)
0 diff
(100 %id)
DB054099 testis .g 138 to 707 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BI834951 pooled pancreas and spleen .g 156 to 935 1 to 781       781/781
(100 %)
2 diff
(99.8 %id)
TI_57167109   .g 156 to 935 31 to 811       781/811
(96 %)
8 diff
(99.1 %id)
BX394230 Neuroblastoma Cot 25-normalized .g 1031 to 2156 1111 to 1   fully sequenced,   1111/1111
(100 %)
28 diff
(97.5 %id)
AL581609 B cells (Ramos cell line), B cells from Burkitt lymphoma .g 1114 to 2149 1026 to 1   fully sequenced,   1026/1026
(100 %)
37 diff
(96.4 %id)
BX414015 B cells (Ramos cell line) .g 1287 to 2187 901 to 1       901/906
(99 %)
12 diff
(98.7 %id)
BX339247 Placenta Cot 25-normalized .g 1397 to 2162 767 to 1       767/767
(100 %)
5 diff
(99.4 %id)
BX333360 Neuroblastoma Cot 25-normalized .g 1422 to 2141 720 to 1       720/721
(99 %)
2 diff
(99.8 %id)
AU159482 thyroid gland .g 1764 to 2197 434 to 1       434/442
(98 %)
0 diff
(100 %id)
BU940249 mixed (pool of 40 RNAs) .h 1 to 740 1 to 746 exact tiling clone,   746/784
(95 %)
11 diff
(98.6 %id)
CR598349 fetal brain .i 1 to 1642 1 to 1642 exact tiling clone,   1642/1642
(100 %)
0 diff
(100 %id)
BX459931 brain, fetal brain .i 2 to 1057 1 to 1048       1048/1048
(100 %)
12 diff
(98.9 %id)
CN418673 embryonic stem cells, cell lines H1, H7, andH9 .i 67 to 611 1 to 545       545/545
(100 %)
1 diff
(99.9 %id)
BX459968 brain, fetal brain .j 1 to 935 1 to 932   tiling clone,   932/932
(100 %)
5 diff
(99.5 %id)
CN418674 embryonic stem cells, DMSO-treated H9 cellline .j 34 to 464 1 to 432       432/435
(99 %)
2 diff
(99.6 %id)
TI_57219423   .j 37 to 832 65 to 865       801/871
(91 %)
37 diff
(95.8 %id)
BI757716 brain .j 43 to 829 1 to 792       792/801
(98 %)
22 diff
(97.3 %id)
BM744057 Ascites, stomach .j 66 to 583 1 to 519       519/519
(100 %)
1 diff
(99.9 %id)
BM743602 Ascites, stomach .j 66 to 632 1 to 566       566/566
(100 %)
1 diff
(99.9 %id)
BM767522 Ascites, stomach .j 66 to 720 1 to 655       655/655
(100 %)
0 diff
(100 %id)
BM767116 Ascites, stomach .j 66 to 734 1 to 669       669/669
(100 %)
0 diff
(100 %id)
BM766712 Ascites, stomach .j 66 to 474 1 to 409       409/409
(100 %)
0 diff
(100 %id)
BM766737 Ascites, stomach .j 66 to 416 1 to 351       351/351
(100 %)
0 diff
(100 %id)
BM767615 Ascites, stomach .j 66 to 581 1 to 516       516/516
(100 %)
0 diff
(100 %id)
BM767860 Ascites, stomach .j 66 to 276 1 to 211       211/211
(100 %)
0 diff
(100 %id)
TI_57163850   .j 70 to 867 23 to 825       803/936
(85 %)
16 diff
(98.3 %id)
CN418672 embryonic stem cells, cell lines H1, H7, andH9 .j 76 to 502 1 to 427       427/427
(100 %)
3 diff
(99.3 %id)
BC048257 Pancreas, Spleen, adult pooled .j 77 to 1701 1 to 1625 exact tiling clone, AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 1625/1625
(100 %)
1 diff
(100.0 %id)
BI834306 pooled pancreas and spleen .j 77 to 867 1 to 796       796/907
(87 %)
12 diff
(98.7 %id)
CB270691 adipose .j 82 to 200 1 to 119       119/119
(100 %)
1 diff
(99.2 %id)
BM919401 pooled pancreas and spleen .j 88 to 695 1 to 608       608/1355
(44 %)
7 diff
(99.5 %id)
CN275001 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .j 95 to 588 1 to 494       494/494
(100 %)
3 diff
(99.4 %id)
BQ683454 melanotic melanoma, cell line, skin .j 108 to 503 1 to 396       396/986
(40 %)
11 diff
(98.9 %id)
BQ682596 melanotic melanoma, cell line, skin .j 108 to 934 1 to 835       835/885
(94 %)
21 diff
(97.7 %id)
BE897422 melanotic melanoma, skin .j 119 to 608 6 to 488       483/701
(68 %)
15 diff
(97.9 %id)
BM920055 pooled pancreas and spleen .j 122 to 750 1 to 627       627/1092
(57 %)
14 diff
(98.8 %id)
CR989766 T-Lymphocytes .j 139 to 938 1 to 801   tiling clone,   801/844
(94 %)
5 diff
(99.5 %id)
DR006584 Spleen .j 139 to 869 9 to 738       730/738
(98 %)
9 diff
(98.8 %id)
CN418675 embryonic stem cells, cell lines H1, H7, andH9 .j 154 to 275 1 to 122       122/122
(100 %)
0 diff
(100 %id)
BE560142 Burkitt lymphoma, lymph .j 203 to 831 1 to 628       628/1104
(56 %)
15 diff
(98.7 %id)
BM153333 leukopheresis .j 243 to 571 1 to 328       328/329
(99 %)
12 diff
(96.4 %id)
BE676053 B-cell, chronic lymphotic leukemia .j 263 to 675 413 to 1       413/414
(99 %)
1 diff
(99.8 %id)
BM749458 Ascites, stomach .j 366 to 499 1 to 134       134/134
(100 %)
0 diff
(100 %id)
AU309759 neuroblastoma .j 438 to 902 1 to 556       435/556
(78 %)
14 diff
(97.5 %id)
M79204   .j 492 to 792 1 to 300       300/300
(100 %)
8 diff
(97.4 %id)
AA312592 Liver .j 584 to 866 1 to 284       284/284
(100 %)
2 diff
(99.3 %id)
AF178686 aorta .j 662 to 2917 1 to 2252 K78E K79A R80P Q81E K82V ... tiling clone, AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 2255/2252
(100 %)
9 diff
(99.7 %id)
BF948885 nervous_normal .j 732 to 889 166 to 10       157/166
(94 %)
0 diff
(100 %id)
BF954988.
matches multiple genes
nervous_normal .j 732 to 876 149 to 5     also hits gene PMS2L3 145/149
(97 %)
0 diff
(100 %id)
TI_149311345   .j 817 to 1701 960 to 84 S2V E3N W4G P6S R7T ... AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 877/993
(88 %)
24 diff
(97.6 %id)
BU689389 lung .j 926 to 1701 791 to 19 S2V E3N W4G P6S R7T ... AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 773/788
(98 %)
6 diff
(99.3 %id)
DR761537 embryonic stem .j 935 to 1698 782 to 18 exact AAA Submitted on the opposite strand 765/765
(100 %)
1 diff
(99.9 %id)
BF343750 brain, glioblastoma with EGFR amplification .j 941 to 1789 1 to 852 L54W D55M A56Q E57S Q59R ...     854/863
(98 %)
41 diff
(95.3 %id)
BG576380 breast, mammary adenocarcinoma, cell line .j 965 to 1680 1 to 715       715/938
(76 %)
12 diff
(98.8 %id)
CD632181   .j 986 to 1477 499 to 9       491/499
(98 %)
7 diff
(98.6 %id)
N98585 lung .j 1015 to 1185 1 to 171       171/178
(96 %)
1 diff
(99.5 %id)
CN259764 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .j 1035 to 1633 1 to 599       599/599
(100 %)
1 diff
(99.9 %id)
CU449390 epidermis .j 1080 to 1821 21 to 762       742/762
(97 %)
7 diff
(99.1 %id)
AU122783 mammary gland .j 1114 to 1905 2 to 795   capped   794/796
(99 %)
10 diff
(98.8 %id)
DB191745 lung, tumor tissue .j 1122 to 1708 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
BM853476 Ascites, stomach .j 1124 to 1592 1 to 469       469/469
(100 %)
1 diff
(99.8 %id)
AW403180 lymph .j 1168 to 1677 1 to 509       509/509
(100 %)
7 diff
(98.7 %id)
TI_154139733   .j 1174 to 1781 81 to 686       606/607
(99 %)
11 diff
(98.2 %id)
CB152999 brain .j 1186 to 1814 1 to 629       629/629
(100 %)
1 diff
(99.9 %id)
TI_153990914   .j 1201 to 1701 595 to 95   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 501/621
(80 %)
1 diff
(99.9 %id)
DA073026 cerebellum .j 1204 to 1769 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
AW206812   .j 1205 to 1701 514 to 18   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 497/497
(100 %)
1 diff
(99.8 %id)
N69983 lung .j 1264 to 1714 453 to 1       453/458
(98 %)
3 diff
(99.4 %id)
AW439777 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .j 1264 to 1700 439 to 2       438/459
(95 %)
0 diff
(100 %id)
BF685746 leiomyosarcoma cell line, uterus .j 1274 to 2012 1 to 739       739/741
(99 %)
9 diff
(98.8 %id)
AI874317 ovary, tumor, 5 pooled (see description) .j 1281 to 1697 418 to 2       417/418
(99 %)
0 diff
(100 %id)
AA077927   .j 1282 to 1400 1 to 119       119/119
(100 %)
0 diff
(100 %id)
AA534391 colon .j 1291 to 1700 438 to 30   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 409/409
(100 %)
6 diff
(98.6 %id)
AA534392 colon .j 1291 to 1700 439 to 30   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 410/410
(100 %)
3 diff
(99.3 %id)
AW467874 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .j 1303 to 1700 398 to 2       397/398
(99 %)
0 diff
(100 %id)
BU501736 brain, neuroblastoma, cell line .j 1396 to 2130 1 to 750       750/970
(77 %)
26 diff
(97.4 %id)
DB516132 testis .j 1418 to 1697 1 to 278     Submitted on the opposite strand 278/278
(100 %)
17 diff
(93.9 %id)
TI_154188027   .j 1427 to 1953 120 to 645       526/923
(56 %)
33 diff
(96.5 %id)
AA807841 normal prostate, Prostate .j 1428 to 1700 307 to 35   AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 273/273
(100 %)
0 diff
(100 %id)
BQ056439 lymph, lymphoma, cell line .j 1428 to 2122 1 to 704       704/1103
(63 %)
21 diff
(98.1 %id)
BQ056596 lymph, lymphoma, cell line .j 1428 to 2222 1 to 804       804/1099
(73 %)
13 diff
(98.9 %id)
AI872585 adenocarcinoma, Pancreas .j 1493 to 1694 245 to 43   AAA   203/209
(97 %)
0 diff
(100 %id)
BE789039 large cell carcinoma, lung .j 1516 to 2211 1 to 708       708/971
(72 %)
34 diff
(96.5 %id)
BM825041 Ascites, stomach .j 1537 to 2033 1 to 497       497/497
(100 %)
0 diff
(100 %id)
AA425835 ovarian tumor, ovary .j 1557 to 1697 148 to 8       141/148
(95 %)
0 diff
(100 %id)
BX454838 brain, fetal brain .j 2352 to 2925 578 to 7   tiling clone,   572/838
(68 %)
0 diff
(100 %id)
AU148284 mammary gland .j 2362 to 2917 553 to 1       553/556
(99 %)
16 diff
(97.2 %id)
DA054128 cerebellum .k-u 1 to 539 2 to 541 R37L L38A M39H K40E N41E ... tiling clone, capped   540/540
(100 %)
1 diff
(99.9 %id)
DA842099 placenta .k-u 27 to 572 2 to 548 A28G E29G E30G Q31A K32E ... tiling clone, capped   547/547
(100 %)
1 diff
(99.9 %id)
DA069338 cerebellum .k-u 31 to 609 2 to 581 S7A R37L L38A M39H K40E ... capped   580/580
(100 %)
2 diff
(99.7 %id)
DA091033 cerebellum .k-u 34 to 565 2 to 534 A51G R52P P53S R54E P55A ... capped   533/533
(100 %)
1 diff
(99.9 %id)
CV373470 prostate_tumor .k-u 336 to 526 1 to 195       195/195
(100 %)
12 diff
(93.9 %id)
DB351399 uterus .k-u 501 to 1042 542 to 1   tiling clone,   542/542
(100 %)
0 diff
(100 %id)
AW006820 colon .k-u 537 to 1042 507 to 2       506/507
(99 %)
0 diff
(100 %id)
AA312551 Liver .k-u 587 to 1052 464 to 1   tiling clone,   464/496
(93 %)
7 diff
(98.6 %id)
DA530437 brain .l 1 to 600 2 to 601 exact tiling clone, capped   600/600
(100 %)
0 diff
(100 %id)
DA561992 heart .m 1 to 384 8 to 391 S7A tiling clone, capped   390/390
(100 %)
1 diff
(99.8 %id)
AW975700.
matches multiple genes
  .n-u 1 to 556 556 to 1   tiling clone, Submitted on the opposite strand, also hits gene POLR2J_ 556/556
(100 %)
7 diff
(98.8 %id)
BY798120.
matches multiple genes
eye .n-u 91 to 719 1 to 629   tiling clone, also hits gene POLR2J_ 629/629
(100 %)
2 diff
(99.7 %id)
BG959592.
matches multiple genes
colon .n-u 126 to 436 1 to 314     also hits gene PMS2L4, POLR2J_ 314/314
(100 %)
9 diff
(97.2 %id)
AW591398.
matches multiple genes
uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .n-u 127 to 558 434 to 3   tiling clone, also hits gene POLR2J_, RASA4PandPOLR2J4 432/434
(99 %)
0 diff
(100 %id)
BE645895 Prostate .n-u 135 to 553 419 to 1       419/493
(84 %)
2 diff
(99.6 %id)
CN278195.
matches multiple genes
embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n-u 148 to 731 1 to 584     also hits gene POLR2J_ 584/584
(100 %)
2 diff
(99.7 %id)
BI015269.
matches multiple genes
lung_tumor .n-u 160 to 515 369 to 15   tiling clone, also hits gene POLR2J_ 355/369
(96 %)
0 diff
(100 %id)
BI016496.
matches multiple genes
lung_tumor .n-u 160 to 491 337 to 2     also hits gene POLR2J_ 336/337
(99 %)
0 diff
(100 %id)
BF880900.
matches multiple genes
lung_tumor .n-u 179 to 518 344 to 6     Submitted on the opposite strand, also hits gene POLR2J_ 339/361
(93 %)
0 diff
(100 %id)
AW841711.
matches multiple genes
colon_normal .n-u 194 to 415 222 to 1   tiling clone, also hits gene PMS2L3, PMS2L4, POLR2J_, RASA4PandPOLR2J4, UPK3B 222/234
(94 %)
17 diff
(92.8 %id)
EC494804.
matches multiple genes
Prostate .n-u 194 to 299 1 to 106     also hits gene POLR2J_ 106/106
(100 %)
2 diff
(98.2 %id)
AA077098.
matches multiple genes
brain .n-u 216 to 498 282 to 1   tiling clone, also hits gene PMS2L3, POLR2J_, RASA4PandPOLR2J4, UPK3B 282/284
(99 %)
2 diff
(99.3 %id)
AI500451.
matches multiple genes
moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .n-u 252 to 555 310 to 7     also hits gene POLR2J_, RASA4PandPOLR2J4 304/311
(97 %)
0 diff
(100 %id)
AA419599.
matches multiple genes
germinal center B cell .n-u 258 to 557 1 to 300     also hits gene POLR2J_ 300/300
(100 %)
0 diff
(100 %id)
AI866126.
matches multiple genes
uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .n-u 286 to 555 277 to 7     also hits gene PMS2L3, PMS2L4, POLR2J_, RASA4PandPOLR2J4, UPK3B 271/277
(97 %)
0 diff
(100 %id)
CN417622.
matches multiple genes
embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .n-u 316 to 518 1 to 203     also hits gene POLR2J_ 203/203
(100 %)
2 diff
(99.1 %id)
CA950992 Pancreas, Purified pancreatic islet .n-u 438 to 907 109 to 575   tiling clone,   467/575
(81 %)
6 diff
(99.0 %id)
BI001436.
matches multiple genes
head_normal .n-u 565 to 1097 532 to 2   tiling clone, also hits gene PMS2L3, PMS2L4, POLR2J_, RASA4PandPOLR2J4, spoyskuby 531/535
(99 %)
0 diff
(100 %id)
ES311397.
matches multiple genes
frontal balding hair, skin .n-u 576 to 765 1 to 190   tiling clone, also hits gene PMS2L3, POLR2J_, spoyskuby 190/190
(100 %)
3 diff
(98.5 %id)
AW748602.
matches multiple genes
breast .n-u 609 to 1137 6 to 537   tiling clone, also hits gene PMS2L4 532/537
(99 %)
28 diff
(94.8 %id)
AW748605.
matches multiple genes
breast .n-u 640 to 1224 583 to 5   tiling clone, also hits gene POLR2J_ 579/583
(99 %)
0 diff
(100 %id)
BQ343240.
matches multiple genes
nervous_normal .n-u 828 to 1166 1 to 340   tiling clone, also hits gene POLR2J_, spoyskuby 340/340
(100 %)
15 diff
(95.6 %id)
AA078563.
matches multiple genes
placenta .n-u 831 to 1124 1 to 294   tiling clone, also hits gene POLR2J_, RASA4PandPOLR2J4, spoyskuby 294/294
(100 %)
2 diff
(99.4 %id)
AA610550.
matches multiple genes
lung, lung tumor .n-u 843 to 1235 392 to 1   tiling clone, also hits gene PMS2L3, POLR2J_, RASA4PandPOLR2J4, spoyskuby 392/392
(100 %)
14 diff
(96.5 %id)
BC141857 Clones donated by RIKEN .n-u 1197 to 2828 483 to 2115 R3G Q13R H19R T22A K30E ... tiling clone, AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 1633/2115
(77 %)
6 diff
(99.8 %id)
CA406165 adipose .n-u 1342 to 1887 1 to 547   tiling clone,   547/551
(99 %)
25 diff
(95.5 %id)
CN415212 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n-u 1381 to 1958 1 to 582       582/582
(100 %)
19 diff
(96.8 %id)
BE699552 nervous_normal .n-u 1421 to 1763 350 to 1   tiling clone,   350/350
(100 %)
19 diff
(94.6 %id)
BX471692   .n-u 1631 to 2223 593 to 1       593/593
(100 %)
10 diff
(98.4 %id)
DB343114.
matches multiple genes
thymus .n-u 1751 to 2283 534 to 1   tiling clone, also hits gene FDPSL2AandPMS2L11 534/534
(100 %)
0 diff
(100 %id)
AA078183.
matches multiple genes
  .n-u 1783 to 2037 255 to 1     also hits gene POLR2J_ 255/255
(100 %)
2 diff
(99.3 %id)
AA078213.
matches multiple genes
  .n-u 1802 to 2034 234 to 2     also hits gene POLR2J_ 233/234
(99 %)
0 diff
(100 %id)
AA772037.
matches multiple genes
parathyroid gland, parathyroid tumor .n-u 1879 to 2250 371 to 1     also hits gene POLR2J_ 371/371
(100 %)
10 diff
(97.4 %id)
AA826164.
matches multiple genes
ovary .n-u 1896 to 2275 1 to 380   tiling clone, also hits gene POLR2J_ 380/380
(100 %)
7 diff
(98.2 %id)
BQ322232.
matches multiple genes
colon .n-u 1929 to 2171 246 to 3   tiling clone, also hits gene PMS2L3, POLR2J_ 244/246
(99 %)
0 diff
(100 %id)
BF918713 nervous_tumor .n-u 1953 to 2282 357 to 28     Submitted on the opposite strand 330/357
(92 %)
0 diff
(100 %id)
R92911 liver and spleen .n-u 2378 to 2684 1 to 307   tiling clone,   307/310
(99 %)
8 diff
(97.5 %id)
DB450673 testis .o 1 to 491 1 to 493   tiling clone,   493/493
(100 %)
11 diff
(97.8 %id)
CF137744 lymph .o 24 to 414 1 to 391   tiling clone,   391/391
(100 %)
8 diff
(98.0 %id)
TI_154167368   .o 31 to 527 80 to 577       498/498
(100 %)
9 diff
(98.2 %id)
BF511835   .o 297 to 785 506 to 18 exact AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 489/489
(100 %)
1 diff
(99.8 %id)
AW197305 pooled germ cell tumors .o 319 to 785 468 to 1 exact     468/469
(99 %)
4 diff
(99.2 %id)
AA996066 breast .o 341 to 786 450 to 5 V13M M37I V47M G59R     446/450
(99 %)
6 diff
(98.7 %id)
AI656920 pooled germ cell tumors .o 341 to 787 447 to 1 exact     447/447
(100 %)
1 diff
(99.8 %id)
AI289213 2 pooled tumors (clear cell type), Kidney .o 345 to 787 444 to 2 exact tiling clone,   443/445
(99 %)
0 diff
(100 %id)
AI949914 2 pooled tumors (clear cell type), Kidney .o 362 to 787 429 to 4 exact     426/429
(99 %)
0 diff
(100 %id)
AI129946 uterus .o 465 to 785 321 to 1       321/321
(100 %)
0 diff
(100 %id)
AL560772 B cells from Burkitt lymphoma .p 1 to 949 1 to 944 A88X tiling clone, fully sequenced,   944/944
(100 %)
6 diff
(99.4 %id)
AL560771 B cells from Burkitt lymphoma .p 571 to 934 364 to 1 F100X tiling clone, fully sequenced,   364/364
(100 %)
0 diff
(100 %id)
TI_154134300   .q 1 to 447 561 to 112 L100Q tiling clone,   519/876
(59 %)
6 diff
(99.4 %id)
AL833837 uterus .r 1 to 2044 1 to 2044 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 2044/2044
(100 %)
2 diff
(100.0 %id)
AA481031 germinal center B cell .s 1 to 308 1 to 308     Submitted on the opposite strand 308/308
(100 %)
0 diff
(100 %id)
AA769080 germinal center B cell .s 1 to 544 1 to 544   tiling clone, Submitted on the opposite strand 544/544
(100 %)
0 diff
(100 %id)
DY655736 pooled .s 386 to 618 233 to 1       233/291
(80 %)
1 diff
(99.7 %id)
DY655786 pooled .s 391 to 619 229 to 1       229/229
(100 %)
1 diff
(99.6 %id)
DY655735.
matches multiple genes
pooled .s 433 to 665 1 to 233   tiling clone, also hits gene PMS2L3 233/233
(100 %)
4 diff
(98.3 %id)
DC424445   .t 1 to 748 2 to 754 R39S tiling clone,   754/771
(97 %)
15 diff
(98.1 %id)
AK300574   .t 52 to 924 1 to 873   tiling clone,   873/873
(100 %)
1 diff
(99.9 %id)
DC384288   .t 52 to 532 1 to 481       481/481
(100 %)
1 diff
(99.8 %id)
DC384892   .t 71 to 621 1 to 551   tiling clone,   551/551
(100 %)
1 diff
(99.9 %id)
DC407769 thymus .t 169 to 707 1 to 539       539/539
(100 %)
0 diff
(100 %id)
BU501278 eye, normal pigmented retinal epithelium .t 886 to 1809 1 to 934       934/940
(99 %)
21 diff
(97.8 %id)
BP253922 Kidney .t 906 to 1487 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP296853   .t 911 to 1492 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
AK022536   .t 912 to 2426 1 to 1515   available from FLJ,   1515/1515
(100 %)
5 diff
(99.7 %id)
AU123211   .t 913 to 1539 2 to 627   capped   626/630
(99 %)
7 diff
(98.9 %id)
BX112022 brain .t 915 to 1663 748 to 1   tiling clone, Submitted on the opposite strand 748/748
(100 %)
2 diff
(99.8 %id)
BI160405 epithelioid carcinoma cell line, Pancreas .t 931 to 1609 1 to 671       671/807
(83 %)
11 diff
(98.7 %id)
CR457287   .t 937 to 1477 1 to 541       541/543
(99 %)
2 diff
(99.7 %id)
BP252551 Kidney .t 949 to 1531 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP252870 Kidney .t 950 to 1530 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BX363474   .t 1044 to 2067 1009 to 1     Submitted on the opposite strand 1009/1099
(91 %)
19 diff
(98.3 %id)
BY797468 eye .t 1099 to 1663 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
AW376987 colon .t 1121 to 1755 1 to 635   tiling clone,   635/635
(100 %)
2 diff
(99.7 %id)
CN366873 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .t 1232 to 1865 1 to 634       634/634
(100 %)
2 diff
(99.7 %id)
D31041   .t 1302 to 1559 1 to 259       259/259
(100 %)
1 diff
(99.7 %id)
D31415   .t 1302 to 1528 1 to 227       227/227
(100 %)
1 diff
(99.6 %id)
BE906651 epithelioid carcinoma, Pancreas .t 1312 to 2073 1 to 756       756/758
(99 %)
11 diff
(98.6 %id)
CB594921 Blood, promyelocytic leukemia .t 1314 to 2145 1 to 836       836/879
(95 %)
17 diff
(98.1 %id)
BU163158 melanotic melanoma, cell line, skin .t 1364 to 2094 1 to 737       737/907
(81 %)
24 diff
(97.4 %id)
BG748378 eye, normal pigmented retinal epithelium .t 1412 to 2132 1 to 721       721/722
(99 %)
4 diff
(99.5 %id)
TI_45133833   .t 1444 to 2191 65 to 814       750/750
(100 %)
14 diff
(98.2 %id)
BG168467 hypernephroma, cell line, Kidney .t 1480 to 2237 1 to 752       752/947
(79 %)
19 diff
(98.0 %id)
BQ230376 epithelioid carcinoma, Pancreas .t 1549 to 2371 1 to 825   tiling clone,   825/878
(93 %)
21 diff
(97.7 %id)
AA306076   .t 1723 to 2152 1 to 432       432/432
(100 %)
2 diff
(99.6 %id)
AA742230 germinal center B cell .t 1744 to 2149 424 to 22   AAA   403/403
(100 %)
3 diff
(99.3 %id)
CD369197 Alveolar Macrophage, lung .t 1835 to 2426 610 to 19   tiling clone, AAA   592/592
(100 %)
1 diff
(99.9 %id)
DR760643 embryonic stem .t 1836 to 2586 752 to 2     Submitted on the opposite strand 751/752
(99 %)
0 diff
(100 %id)
TI_154146234   .t 1859 to 2532 751 to 79     Submitted on the opposite strand 673/675
(99 %)
25 diff
(96.3 %id)
BM801114 embryonal carcinoma, cell line, testis .t 1883 to 2614 260 to 1002   tiling clone,   743/1060
(70 %)
6 diff
(99.5 %id)
TI_154160230   .t 1903 to 2426 640 to 117   AAA Submitted on the opposite strand 524/524
(100 %)
6 diff
(98.9 %id)
AU154166   .t 1914 to 2426 512 to 1       512/515
(99 %)
9 diff
(98.3 %id)
AW468349 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .t 1943 to 2426 484 to 1       484/484
(100 %)
3 diff
(99.4 %id)
TI_154166629   .t 1999 to 2600 687 to 81     Submitted on the opposite strand 607/819
(74 %)
18 diff
(97.9 %id)
AW504168 lymph .t 2038 to 2426 426 to 38   AAA Submitted on the opposite strand 389/389
(100 %)
1 diff
(99.8 %id)
AA678950   .t 2050 to 2436 387 to 1       387/387
(100 %)
2 diff
(99.5 %id)
CA773454 Pancreas, Purified pancreatic islet .t 2075 to 2592 518 to 1       518/518
(100 %)
2 diff
(99.7 %id)
CF137252 lymph .t 2077 to 2600 532 to 8     Submitted on the opposite strand 525/532
(98 %)
0 diff
(100 %id)
AA742316 germinal center B cell .t 2085 to 2149 86 to 22   AAA   65/65
(100 %)
0 diff
(100 %id)
CF136681 lymph .t 2085 to 2426 387 to 46   AAA Submitted on the opposite strand 342/342
(100 %)
1 diff
(99.8 %id)
BF448904 sympathetic trunk .t 2091 to 2427 337 to 1       337/337
(100 %)
1 diff
(99.8 %id)
CX783731 human embryonic stem cells .t 2256 to 3033 1 to 777   tiling clone,   777/777
(100 %)
5 diff
(99.4 %id)
CN277126 embryonic stem cells, DMSO-treated H9 cellline .t 2489 to 2677 1 to 188       188/188
(100 %)
1 diff
(99.5 %id)
AA375649 lung .t 2573 to 2800 1 to 228   tiling clone,   228/228
(100 %)
0 diff
(100 %id)
AV728369 hypothalamus .t 2882 to 3381 1 to 500   tiling clone, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 500/500
(100 %)
4 diff
(99.2 %id)
BG991326 head_neck .u-u 1 to 536 14 to 549   tiling clone,   536/549
(97 %)
6 diff
(99.0 %id)
CD656933 Embryonic Stem cells .u-u 543 to 1387 11 to 855   tiling clone,   845/859
(98 %)
11 diff
(98.8 %id)
AW272868 colon, moderately-differentiated adenocarcinoma .u-u 607 to 1094 488 to 1       488/488
(100 %)
6 diff
(98.8 %id)
BG899284 cartilage .u-u 1305 to 1659 73 to 428   tiling clone,   356/365
(97 %)
6 diff
(98.4 %id)
BU660773 blood .u-u 1594 to 2047 1 to 454 T37K S39F H40N V47G W49G ... tiling clone,   454/454
(100 %)
30 diff
(93.4 %id)
CR735237 lymph, lymphoma, cell line .va 1 to 292 39 to 331   tiling clone,   293/336
(87 %)
8 diff
(97.7 %id)
BQ054843 lymph, lymphoma, cell line .va 2 to 1011 1 to 1020       1020/1061
(96 %)
31 diff
(97.1 %id)
BQ055887 lymph, lymphoma, cell line .va 2 to 822 1 to 826       826/1097
(75 %)
14 diff
(98.8 %id)
BQ056479 lymph, lymphoma, cell line .va 2 to 891 1 to 895   tiling clone,   895/1043
(85 %)
19 diff
(98.2 %id)
BQ063468 lymph, lymphoma, cell line .va 2 to 798 1 to 813       813/1174
(69 %)
15 diff
(98.8 %id)
BQ065576 lymph, lymphoma, cell line .va 2 to 822 1 to 837       837/901
(92 %)
24 diff
(97.4 %id)
AA481082 germinal center B cell .va 596 to 1009 415 to 1   tiling clone, Submitted on the opposite strand 415/415
(100 %)
1 diff
(99.8 %id)
BF378563 uterus .va 939 to 1173 3 to 235   tiling clone,   233/243
(95 %)
6 diff
(97.6 %id)
DB470178.
matches multiple genes
hippocampus .va 1108 to 1351 1 to 244   tiling clone, also hits gene hikamu 244/244
(100 %)
5 diff
(98.0 %id)
CK005661 brain/CNS, Human Brain - Frontal Cortex .va 1325 to 1928 1 to 604   tiling clone,   604/615
(98 %)
5 diff
(99.2 %id)
BF772051 epid_tumor .va 1366 to 1777 1 to 411       411/412
(99 %)
4 diff
(99.1 %id)
BF809202 colon_ins .va 1380 to 1888 1 to 537       537/537
(100 %)
38 diff
(93.0 %id)
BQ321745 colon .va 1395 to 1840 8 to 450       443/458
(96 %)
11 diff
(97.6 %id)
AW812446 stomach .va 1398 to 1794 19 to 411   tiling clone,   393/411
(95 %)
6 diff
(98.6 %id)
BF931245 nervous_tumor .va 1434 to 1731 1 to 296       296/296
(100 %)
8 diff
(97.3 %id)
BQ321516 colon .va 1495 to 1721 12 to 236       225/239
(94 %)
13 diff
(94.6 %id)
BQ376325 testis_normal .va 1663 to 1861 1 to 196       196/203
(96 %)
6 diff
(97.1 %id)
D61003   .vb-u 1 to 354 1 to 355   tiling clone,   355/355
(100 %)
5 diff
(98.6 %id)
BG568974 Liver .vb-u 6 to 794 1 to 803   tiling clone,   803/822
(97 %)
34 diff
(95.9 %id)
BQ004281 Chondrosarcoma, Left Pelvis .vb-u 726 to 1307 600 to 19 exact tiling clone, AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 582/582
(100 %)
2 diff
(99.7 %id)
BF083240 colon .vb-u 874 to 1380 506 to 1 exact tiling clone,   506/521
(97 %)
38 diff
(92.8 %id)
BF089004 head_neck .vb-u 935 to 1130 201 to 9       193/228
(84 %)
0 diff
(100 %id)
H19634 brain .vb-u 938 to 1307 1 to 374 exact     374/379
(98 %)
7 diff
(98.2 %id)
AA078294 placenta .vb-u 966 to 1243 1 to 278       278/278
(100 %)
0 diff
(100 %id)
G30792   .vb-u 966 to 1243 1 to 278       278/278
(100 %)
0 diff
(100 %id)
H19636 brain .vb-u 972 to 1307 342 to 1       342/352
(97 %)
9 diff
(97.5 %id)
AA910849 Kidney .vb-u 972 to 1427 456 to 1   tiling clone,   456/456
(100 %)
0 diff
(100 %id)
BF771241 epid_tumor .vb-u 990 to 1225 247 to 12     Submitted on the opposite strand 236/260
(90 %)
0 diff
(100 %id)
BC063572 Eye, retinoblastoma .vc 1 to 982 1 to 982 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/21 A in genome downstream of last aligned base) 982/982
(100 %)
1 diff
(99.9 %id)
BE781995 eye, retinoblastoma .vc 25 to 668 1 to 655   available from MGC,   655/847
(77 %)
36 diff
(95.8 %id)
BF796278 lymph, lymphoma, cell line .vd 1 to 678 1 to 682 E61R V62* tiling clone,   682/690
(98 %)
12 diff
(98.3 %id)
AI268076 carcinoid, lung .vd 143 to 212 70 to 1   tiling clone,   70/70
(100 %)
0 diff
(100 %id)
CA777103 Pancreas, Purified pancreatic islet .ve-u 1 to 177 1 to 171   tiling clone,   171/171
(100 %)
5 diff
(97.1 %id)
TI_154168677   Gene PMS2L12andPRKRIP1andORAI2, variant not shown         This clone was ignored    
174 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c-u, .d, .e, .f, .g, .h, .i, .j, .k-u, .l, .m, .n-u, .o, .p, .q, .r, .s, .t, .u-u, .va, .vb-u, .vc, .vd, .ve-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI